Investors with losses over $500,000 are encouraged to contact the Firm

Glancy Prongay & Murray LLP (“GPM”) announces that a class action lawsuit has been filed on behalf of investors who purchased Adeptus Health Inc. (“Adeptus Health” or the “Company”) (NYSE: ADPT) securities pursuant and/or traceable to one of the Company's public offerings (the "Offerings" including the June 2014 Initial Public Offering, the May 2015 Secondary Offering, the July 2015 Secondary Offering, and the June 2016 Secondary Offering), or between June 25, 2014 and November 1, 2016, inclusive (the “Class Period”). Adeptus investors have until December 27, 2016 to file a lead plaintiff motion.

Investors suffering losses on their Adeptus investments are encouraged to contact Lesley Portnoy of GPM to discuss their legal rights in this class action at 310-201-9150 or by email to shareholders@glancylaw.com.

The Complaint filed in this lawsuit alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose: (1) that Adeptus engaged in an extensive predatory billing practice, predominantly in connection with lower acuity level patients; (2) that the Company's predatory billing practices subjected the Company to several known and undisclosed risks, including financial risks, reputational risks, risks associated with improper financial reporting, civil or criminal sanctions, and exclusion from federal and state healthcare programs; (3) that Adeptus' financial statements were inadequate with Generally Accepted Accounting Principles; (4) contrary to Adeptus' statements about its practice of referring lower acuity patients to urgent care facilities, Adeptus regularly treated lower acuity patients and unreasonably billed for services; (5) consequently, Adeptus lacked a reasonable basis for its statements about its business and future financial prospects at all relevant times.

On November 1, 2016, after hours, the company reported 3rd quarter earnings, and reported revenues that fell below estimates, and lowered its 2016 full year revenue guidance. Adeptus CEO Thomas Hall stated that results “were disappointing due to weaker than expected volumes in non-HOPD markets, collection issues associated with our third party billing agent and higher costs associated with the opening of three hospitals in the second half of the year, in Denver, Houston and Colorado Springs.” The company also announced that CEO Thomas Hall will retire as chairman. On this news Adeptus shares dropped in value thereby injuring investors.

If you purchased shares of Adeptus during the Class Period or pursuant and/or traceable to the Company's SPO you may move the Court no later than December 27, 2016 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at http://glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP, Los AngelesLesley Portnoy, 310-201-9150 or 888-773-9224shareholders@glancylaw.comhttps://www.glancylaw.com